Robert Nelsen Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Robert Nelsen is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 584,148 shares of VIR, which is worth approximately $6.13 Million. The most recent transaction as insider was on May 30, 2024, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 584K
1.39% 3M change
1.39% 12M change
Total Value Held $6.13 Million

ROBERT NELSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2024
BUY
Grant, award, or other acquisition
-
8,000 Added 1.35%
584,148 Common Stock
May 22 2023
BUY
Grant, award, or other acquisition
-
6,027 Added 1.04%
576,148 Common Stock
Sep 06 2022
BUY
Other acquisition or disposition
-
30,238 Added 5.04%
570,121 Common Stock
Sep 02 2022
BUY
Other acquisition or disposition
-
24,737 Added 4.38%
539,883 Common Stock
Aug 31 2022
BUY
Other acquisition or disposition
-
27,489 Added 5.07%
515,146 Common Stock
Aug 30 2022
BUY
Other acquisition or disposition
-
27,489 Added 5.34%
487,657 Common Stock
Aug 25 2022
BUY
Other acquisition or disposition
-
27,489 Added 5.64%
460,168 Common Stock
Aug 24 2022
BUY
Other acquisition or disposition
-
27,489 Added 5.97%
432,679 Common Stock
Aug 18 2022
BUY
Other acquisition or disposition
-
27,489 Added 6.35%
405,190 Common Stock
Aug 16 2022
BUY
Other acquisition or disposition
-
27,489 Added 6.78%
377,701 Common Stock
Aug 15 2022
BUY
Other acquisition or disposition
-
27,489 Added 7.28%
350,212 Common Stock
Aug 12 2022
BUY
Other acquisition or disposition
-
27,489 Added 7.85%
322,723 Common Stock
Jun 08 2022
BUY
Other acquisition or disposition
-
27,489 Added 8.52%
295,234 Common Stock
Jun 02 2022
BUY
Other acquisition or disposition
-
29,173 Added 9.34%
283,124 Common Stock
May 23 2022
BUY
Grant, award, or other acquisition
-
6,405 Added 2.46%
253,951 Common Stock
Dec 20 2021
BUY
Other acquisition or disposition
-
102,041 Added 29.47%
244,172 Common Stock
Nov 29 2021
BUY
Other acquisition or disposition
-
29,153 Added 17.02%
142,131 Common Stock
Nov 22 2021
BUY
Other acquisition or disposition
-
29,153 Added 20.51%
112,978 Common Stock
Jul 01 2021
BUY
Other acquisition or disposition
-
47,897 Added 36.36%
83,825 Common Stock
Jun 22 2021
BUY
Other acquisition or disposition
-
11,974 Added 25.0%
35,928 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
3,374 Added 10.99%
27,328 Common Stock
Apr 08 2021
BUY
Other acquisition or disposition
-
5,989 Added 20.0%
23,954 Common Stock
Apr 07 2021
BUY
Other acquisition or disposition
-
5,989 Added 25.0%
17,965 Common Stock
Apr 01 2021
BUY
Other acquisition or disposition
-
5,987 Added 33.33%
11,976 Common Stock
Mar 30 2021
BUY
Other acquisition or disposition
-
5,989 Added 50.0%
5,989 Common Stock

Also insider at

BEAM
Beam Therapeutics Inc. Healthcare
Director
KRTX
Karuna Therapeutics, Inc. Healthcare
Director
SANA
Sana Biotechnology, Inc. Healthcare
DNLI
Denali Therapeutics Inc. Healthcare
Director
LYEL
Lyell Immunopharma, Inc. Healthcare
PRME
Prime Medicine, Inc.
Director
RN

Robert Nelsen

Director
Chicago, IL

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR